Drug & intervention

Tagrisso

RxCUI 1721566

Clinical trials3

Recruiting1

Related conditions3

Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

3 shown

A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLCNCT06306456 · 2024-03-05

Whole Genomic Landscape of Advanced EGFR-mutant NSCLCNCT03969823 · 2019-05-23

ACTIVE_NOT_RECRUITING

Neo-adjuvant Trial With AZD9291 in EGFRm+ Stage IIIA/B NSCLCNCT02824952 · 2018-11-01

Conditions being studied

Locally Advanced or Metastatic NSCLC1 Lung Cancer, Non-small Cell1 Non-Small Cell Lung Cancer With EGFR Mutation1

Research locations

ChangshaHunan, China1 HefeiAnhui, China1 JerusalemIsrael1 NanjingJiangsu, China1 SeoulSouth Korea1 ShanghaiShanghai Municipality, China1 ZhengzhouHenan, China1

Leading sponsors

Seoul National University Hospital1 Shaare Zedek Medical Center1 Suzhou Genhouse Bio Co., Ltd.1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.